Webinar: Understanding Fatigue and Insomnia
Fatigue and insomnia after treatment for a brain tumor can come on suddenly and bring dramatic change and disruption to your daily life. On Tuesday, Dec. 3, at 2:00 pm CST, our webinar, “Understanding Fatigue and Insomnia” will explore these two most common brain tumor treatment side effects and provide practical strategies for managing them. This webinar will be presented by Terri S. Armstrong, PhD, APRN-BC, FAANP. There will be time for Q & A with Dr. Armstrong immediately following the presentation. RSVP for “Understanding Fatigue and Insomnia” here.
Scientific Conference Poster Session to Include ABTA Survey Results
ABTA Senior Advisor Mary Lovely, PhD, RN, CNRN, will present findings from her survey of health care professionals entitled “Neuro-Oncology Treatment and Symptom Management Learning Preferences for Health Care Professionals" during the poster session of the upcoming Society for Neuro-Oncology 2013 Scientific Meeting and Education Day in San Francisco. Dr. Lovely's research was accepted by SNO to be presented at a poster session during their upcoming conference. Poster sessions are a presentation of research information by an individual or representatives of research teams at a conference with an academic or professional focus. Lovely is also moderating a panel on symptom management and chairing a session on quality of life programs in the clinical setting.
This year, send a holiday card that gives back. When you purchase holiday cards through the ABTA, we receive 50 percent of the profit from the sale along with 100 percent of any additional donation made. Prices start at $29 per box of 25; cards can be personalized with your name and/or special message. View and order ABTA holiday cards online here or call 888-487-5567.
Careers in Pediatric Neurosurgery
Research published in the Journal of Neurosurgery Pediatrics (November 2013) suggests that there may be a growing disparity between the supply of and demand for both pediatric specialists and neurosurgeons (PNS). PNS fellows in the United States and Canada participated in a web-based survey that assessed their residency training, particularly as it related to training in PNS; exposure to mentoring opportunities from pediatric neurosurgical faculty and their plans for the future; and perceptions about how likely various factors were to influence their decision about whether to pursue a PNS career. The authors suggested opportunities to continue attracting residents to PNS careers. Read the abstract here.
Study Explores Treatment for Fatigue and Depression
Researchers in the Netherlands recently published in Neuro-Oncology (October 2013) the results of a placebo-controlled clinical trial which evaluated the effects of the wakefulness promoting drug, Modafinil (a psychostimulant) on fatigue, depression, health-related quality of life (QOL) and cognitive functioning in patients with a primary brain tumor. Contrary to their expectations, the researchers reported Modafinil did not exceed the effects of placebo with respect to symptom management. The researchers recommend the development of nonpharmacologic interventions aimed specifically at symptom management to ease symptom burden in patients with primary brain tumors. To read the abstract, click here.
Smoking and Neurosurgical Outcomes
Smoking has long been identified as a risk factor for chronic disease; however, researchers from the University of California San Francisco and Yale University suggest that the evidence in the neurosurgical literature demonstrates that tobacco smoking may also be a risk factor for surgical complications. The researchers, including ABTA Scientific Advisory Council member Dr. Mitchel Berger, analyzed a small number of published reports specifically focused on neurosurgical procedures. Their analysis identified higher rates of intraoperative blood loss, greater need for intraoperative transfusions, higher rates of postoperative complications, and, in some patients, shorter survival times among smokers. The article posted in the Journal of Neurosurgery (November 2013). Click here for the abstract.
NYC 5K Drenched in Sunshine and Fall Color
Nearly 1,000 ABTA supporters gathered at Pier 84 along New York's Hudson River last Saturday for the Breakthrough for Brain Tumors NYC 5K Run & Walk. Moving tributes from event committee members and emcees Kate Festa and Aaron Lombardi provided inspiration for participants, who released balloons in a shared moment of remembrance.
"This was my first ever BT5K, and I thank the ABTA so much for making this experience possible," said BT5K participant Monica Mahal. "This 5K was one of the best things I've ever done.”
Visit www.bt5k.org to for a schedule of Breakthrough for Brain Tumors 5Ks in 2014.
Move Further with Team Breakthrough
Challenge yourself and make a big impact in the lives of brain tumor patients and their families. Visit www.abtateambreakthrough.org to see our full listing of 2014 events.
Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing information, support and educational resources for all age groups and all tumor types. For more information, visit www.abta.org or call 800-886-ABTA (2282).
This information is provided by the American Brain Tumor Association, 8550 W. Bryn Mawr Ave., Suite 550, Chicago, IL 60631. For more information about the American Brain Tumor Association, call toll-free 866-659-1030, write firstname.lastname@example.org or visit www.abta.org.
The "American Brain Tumor Association" name and logo, the "Breakthrough for Brain Tumors" name and logo, the "Team Breakthrough" name and logo and "TrialConnect" are registered trademarks of the American Brain Tumor Association. All rights reserved.
Having Fun Raising Funds
To learn more about our events, to search for events in your state, or to learn how to host your own volunteer fundraising event, visit:
Connect with Others at Connections Online
The ABTA's Connections online support community links patients, families, friends and caregivers with each other for support and inspiration. It is a safe place to visit, join and interact with members of the brain tumor community nationally and around the world.
Find a Clinical Trial Through TrialConnect
The ABTA's TrialConnect, a free and confidential service administered by EmergingMed, is offered in English and Spanish. Read more
Our licensed health care professionals provide brain tumor information, support and education for patients, families and health care professionals. Write email@example.com
or call our toll-free CareLine at 800-886-ABTA (2282).